【摘要】目的 探讨神经内分泌剂(ACEI、β-受体阻滞剂)对慢性心力衰竭的疗效。方法 对92例慢性心力衰竭患者在一般治疗基础上加用神经内分泌拮抗剂，观察心功能改善情况，3年内病死率及再住院率。结果 明显改善58例，占63%，好转21例，占22.8%，总有效率85.8%。3年内因心衰恶化再住院19例，占20.7%，3年内死亡12例，占13%，未愈5例，占5.4%，恶化6例，占6.5%。结论 神经分泌拮抗剂可改善慢性心力衰竭患者临床预后，改善心功能，减少再住院率及死亡率。

    【关键词】神经内分泌剂 慢性心力衰竭

    中图分类号：R541.6 文献标识码：A 文章编号：1005-0515(2012)3-029-02

    Treatment of 92 cases of chronic heart failure

    Xu Junfeng

    (Leshan City, Sichuan the Wutongqiao Chinese Medicine Hospital, Sichuan Leshan 614801)

    【Abstract】Objective To investigate the neuroendocrine agents (ACE inhibitors, beta-blockers), chronic heart failure. Methods to improve the situation: on the basis of general treatment on 92 patients with chronic heart failure patients with neuroendocrine antagonists, cardiac function, three years, mortality and readmission rates. Results 58 cases significantly improved, accounting for 63%, improved in 21 cases, accounting for 22.8%, the total efficiency of 85.8%. Deterioration of heart failure three years 19 cases of hospitalization, accounting for 20.7% died within 3 years, 12 cases (13%), five cases healed, accounting for 5.4% deterioration in 6 cases, accounting for 6.5%. Conclusion The neurosecretory antagonists can improve clinical outcomes in patients with chronic heart failure, improve heart function and reduce readmission rates and mortality. ......